Biovica International AB Stock: price and insider trades · Sweden

This page follows insider dealings at Biovica International AB as filed with Finansinspektionen, a company from the Health Care sector. From 3 November 2025 to 3 November 2026, the disclosure feed for Biovica International AB logged 13 filings by 4 insiders.

Not one open-market sale was filed. On the buying side, 3 insiders reported 11 purchases totalling €1.1M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Those buying include 2 board members and 1 chief executive. Fredrik Alpsten filed the largest purchase, €895k, on 18 December 2025.

For context, the typical company on the same exchange (median of 1,032 companies) published 9 filings over the same period, against 13 filings here. Since 2017, the database holds 131 purchases and 4 sales by insiders of the company.

Within a 30-day window, 4 purchases overlapped with buying by a second insider. Purchases made close together by different insiders form what is called a cluster. The clock since the last published purchase (27 October 2026) now reads 12 days. The median gap between trade and publication is zero days: most filings appear on the same day. The regulation allows three business days to notify a trade (MAR article 19).

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.